Data shows Covid-19 vaccine safe, protective in kids: Pfizer/BioNTech Ruchika Sharma21 Sept 2021 8:02 AMNew Delhi: Pfizer Inc and BioNTech SE said on Monday their Covid-19 vaccine induced a robust immune response in 5 to 11 year olds, and they plan to...
Pfizer COVID booster doses only for people 65 and older: USFDA advisers Ruchika Sharma19 Sept 2021 5:00 AMWashington: The US Food and Drug Administration advisory (FDA) committee on Friday (local time) voted unanimously to authorize Pfizer booster shots...
Pfizer gets CDSCO panel marketing authorization for Infliximab Medical Dialogues Team15 Sept 2021 8:22 AMNew Delhi: Granting permission for a local Phase III clinical trial waver, the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Pfizer initially rejected BioNTech offer to develop COVID vaccine MD Bureau14 Sept 2021 3:30 AMLondon: US drug maker Pfizer wrongly assumed that the coronavirus outbreak would be quickly contained and thus declined the offer made by BioNTech to...
Pfizer COVID vaccine for kids aged 12, above approved in South Africa Ruchika Sharma13 Sept 2021 10:26 AMJohannesburg: South Africa's health regulator has approved Pfizer's COVID-19 vaccine for use by children aged 12 and older, paving the way for the...
USFDA accepts Pfizer, Myovant MYFEMBREE review application to treat endometriosis linked pain Ruchika Sharma12 Sept 2021 4:00 AMBasel: Pfizer Inc. and Myovant Sciences have announced that the U.S. Food and Drug Administration (FDA) has accepted for review a...
Moderna COVID vaccine superior to Pfizer, JnJ against Delta, claims study MD Bureau11 Sept 2021 4:00 AMNew York: Moderna's vaccine for Covid-19 is significantly more effective against the Delta variant of the SARS-CoV2 virus than Pfizer or Johnson &...
Booster doses of Pfizer, AstraZeneca COVID vaccines approved in UK MD Bureau10 Sept 2021 7:07 AMLondon: The UK's health regulator has approved Pfizer and AstraZeneca vaccines for booster doses against Covid-19, even as the country's decision on...
To cut wastage, Pfizer to offer smaller packages of COVID vaccine MD Bureau6 Sept 2021 1:46 PMWashington: US drug maker Pfizer aims to roll out smaller packages of its Covid-19 vaccine for public health departments and care providers by...
Pfizer begins Phase 3 trial of RSV vaccine in adults Ruchika Sharma5 Sept 2021 4:30 AMNew York: Pfizer Inc. has recently announced the initiation of RENOIR (RSV vaccine Efficacy study iN Older adults Immunized against RSV disease), a...
Pfizer, Merck launch new trials of oral antiviral drugs for COVID Ruchika Sharma4 Sept 2021 5:30 AMNew Delhi: Pfizer Inc and Merck & Co Inc announced on Wednesday new trials of their experimental oral antiviral drugs for COVID-19 as...
Pfizer COVID vaccine for 5-12 years likely to get nod by October: Ex-USFDA Chief MD Bureau30 Aug 2021 7:02 AMWashington: US drug maker Pfizer's Covid-19 vaccine is likely to get authorisation for providing vaccines to children aged between 5 to 12 by October,...
